For Apheresis Professionals

ASFA 2009 Annual Meeting Presentations

The ASFA 2009 Annual Meeting was held at the Sheraton San Diego Hotel and Marina, San Diego, CA from May 20 - 23, 2009. Posted below are presentations that were delivered at the ASFA 2009 Annual Meeting (for which ASFA has the speaker's permission to make available for education and training purposes).

Disclaimer

Reference to these materials will be useful but not comprehensive in developing appropriate standards of care. Their use does not confer any professional qualification or standard. Publication of these materials does not constitute an endorsement by ASFA. ASFA has not reviewed these materials to ensure consistency with acceptable practices. The views expressed in these materials represent the opinion of the authors. ASFA expressly dislclaims any liability arising from any inaccuracy or misstatement. Each facility and/or individual referring to these materials should analyze the information, practices, and procedures outlined therein to determine their acceptability for use in the context of their own obligations and within their own facility's standards and procedures.

Graduate Medical Education Forum

Introductory Comments and Overview of Graduate Medical Education Committee
Chester Andrzejewski, PhD, MD, FCAP

Resident Training in Apheresis
Georgia Andrianopoulos, MD

American Board of Pathology: Maintenance of Competencies
Rebecca Johnson, MD

PRODS Apheresis Survey Results
Jason Kang, MD

Committee Deliberations
Bruce Sachais, MD, PhD

Opening Combined Symposium: Apheresis State-of-the-Art

Iron and Erythropoiesis in Health and Disease
Susan Leitman, MD

Apheresis Platelets
Mark Brecher, MD

Vasculitis – is Apheresis the Answer?
John Niles, MD

The Role of Apheresis for CNS Disorders – 2009
B. Mark Keegan, MD, FRCP(C)

Francis Morrison, MD Memorial Lecture

Apheresis Medicine: Romancing the Evidence
Robert Weinstein, MD

Plenary Abstract Session

Treatment Outcomes in Idiopathic Thrombotic Thrombocytopenic Purpura: Results of the Serf-TTP Group
Anaadriana Zakarija, MD, MSCI

Mobilization with G-CSF only is Associated with Increased Infusion Toxicity
Laura Cooling, MD, MS

Disease- and Mobilization-Specific Decreases in CD34 Collection Rates with the Cobetm Spectra Autopbpc Kit
Laura Cooling, MD, MS

The Effect of Donor Age on Allogeneic G-CSF Mobilized Peripheral Blood Progenitor Stem Cells (PBPC) Collection
Elie Richa, MD

Relationship between Donor Location during the Donation Process and Donor Characteristics in Predicting Adverse Reactions in a Cohort of 2RBC-Eligible Allogeneic Donors
Robin Cusick, MD

Effect of Concurrent Collection of RBCs on Hematocrit in Apheresis Donors
Jessie Alex, BSN, MSN, HP(ASCP)

A Retrospective Analysis of Two Plasma Exchange Protocols in the Treatment of Antibody-Mediated Rejection following Renal Allograft Transplantation
Jason Kang, MD

Clinical Utility of ADAMTS13 Biomarkers and VWF Multimer Analysis in the Evaluation of Idiopathic TTP
Haifeng Wu, MD

Bacterial Screening of Apheresis Platelet Donations Rarely Identifies Clinically Significant, Occult Infection in the Donor
Richard Benjamin, MD, PhD

Education Session I: Apheresis Operations

Team Building
Tim Weisse, BS, MAM

Measuring Productivity
Laura Collins, RN, BSN, HP(ASCP)

Strategies for Providing Continuing Education
Dennis Harpool

Education Session II: Cellular Therapy

Preparing the Transplant Patient for HPC Collection: A Coordinators Perspective
Christopher Chun, BS, MT(ASCP)

Innovative Approaches to Cell Therapy
Thomas Lane, MD

Scientific Symposium: Normal and Malignant Stem Cells: Evolving Paradigms and Therapeutic Applications

Optimizing the Graft for Hematopoietic Stem Cell Transplantation
Edward Snyder, MD

Gene Therapy: Current Technologies and Clinical Progress
John Tisdale, MD

Revealing the Therapeutic Potential of the Hematopoietic Stem Cell
Gregor Adams, PhD

Cancer Stem Cells
William Matsui, MD

Education Session III: Advanced Therapeutic Apheresis

Apheresis in immunologically Mediated Renal Disorders and Transplantation
Dobri Kiprov, MD

LDL Apheresis
Gina Dargo

Education Session IV: Pediatric Apheresis

Extracorporeal Photopheresis in Pediatric Stem Cell Transplantation
Jennifer Schneiderman, MD

Medical Conditions Treated by Apheresis
Rachel Green, MD

Abstract Session I: Thrombotic Thrombocytopenia Purpura and Miscellaneous Therapeutic Apheresis

Removal of Ultra Large VWF by Filtration and Plasma Apheresis in Patients with Trombotic Trombocytopenic Purpera (TTP)
Jacques Wollersheim, MD

Case Controlled Study of Urinary Tract Infection Associated with Thrombotic Thrombocytopenic Purpura as Compared to Idiopathic Thrombocytopenic Purpura
Yara Park, MD

Is it Quinine TTP/HUS or Quinine TMA?
Jessica Poisson, MD

TTP Presentation and Treatment: The Stony Brook Experience
Jason Chiang, MD

Conceptual Framework for Congenital, Idiopathic, and Drug- and Transplant Associated Thrombotic Thrombocytopenia Purpura (TTP): Importance of Stress, Endothelial Damage, and ADAMTS13 Activity
Anaadriana Zakarija, MD, MSCI

Plasma Exchange as Treatment of Transplantation-Associated Thrombocytopenic Microangiopathy (TA-TMA): Effect of Concomitant Acute Graft-Versus-Host-Disease (GVHD) on Efficacy and Outcome
Kari Mudie, Dip. H.Ed. Nur., Grad. Cert. Apheresis

Use of Therapeutic Plasma Exchange in the Management of a Patient with Atypical Hemolytic Uremic Syndrome Associated with a Newly Discovered Splice Site Mutation in Factor H
Saptarshi Mandal, MD

Why Do Patients with Thrombotic Microangiopathy Die? What Can Be Done About it?
Edwin Taft, MD

Rituximab Does Not Prevent TTP Relapses
Marisa Marques, MD

Long Term Use of Implanted Subcutaneous Ports for Photopheresis
Deborah Schiller, RN

Efficacy of Dual Lumen Implantable Vortex Ports during Isovolemic Hemodilution/Red Blood Cell Exchange in Sickle Cell Disease Patients
Dava Cleveland-Noriega, DO

The "10% Rule": A Retrospective Analysis of a Simplified Method to Determine the Number of Units of Red Cells to Use in Patients with Sickle Cell Anemia and its Sickling Variants Requiring Red Cell Exchange
James Westra, MD

Abstract Session II: Therapeutic Apheresis

Development of an Apheresis Simulator for Education of Pathology Residents and Medical Technologists
Steven Gregurek, MD

Long Term Plasma Exchange for Severe Refractory Hypertriglyceridemia: a Decade of Experience
Deborah Rund, MD

Management of Therapeutic Plasma Exchange-Associated Dilutional Hypofibrinogenemia
Karén Matevosyan, MD

Using Simulation Training to Advance Staff Proficiency in Therapeutic Plasma Exchange
Robin Willis, RN, BSN, HP(ASCP)

Red Blood Cell Exchange: Evaluation of Performances of Fresenius Com.Tec and Cobe Spectra
Ferda Tekinturhan, BSc

What Could be the Reason for the Metabolic Alkalosis during Leukaphereses Procedures?
Volker Witt, MD

Plasma Exchange is Effective in the Relief of Troublesome Pruritus of Primary Biliary Cirrhosis Refractory to Medical Treatment: a Series of Four Cases
Rachel Green, M.B., Ch.B.

Frequency of Sickle Cell Painful Crises with Chronic Red Cell Exchange Transfusion and Association with Hematological Parameters
Joseph McLaughlin, MD

Abstract Session III: Cellular Therapy and Donor Apheresis

The Effects of Age and Medical Comorbidities on Apheresis-Related Toxicity and Product Cell Yields in Adult Peripheral Blood Stem Cell Donors
Michael Linenberger, MD

Significant Thrombocytopenia as an Early Sign of Spontaneous Splenic Rupture in an Allogeneic Stem Cell Donor
Laura Cooling, MD, MS

Development of Apheresis-Specific Tracking and Trending Quality Indicators Based on a "Patient Safety, Access, Satisfaction, Cost/Utilization, Outcome" Model in a Complex Relational Dashboard Database
Elizabeth Barnett, RN,HP(ASCP)

Collection of Hematopoietic Stem Cells from Low Weight Sibling Donors without a Blood Prime
Jennifer Collins, BSN, RN

Use of the Com.Tec Cell Separator for Pbpc Collection: Ongoing Need for Apheresis Operator Interventions
Jennifer Leutenegger, Bachelor of Nursing

Multiple Myeloma Patients have Increased Rate of Citrate Reactions during Peripheral Blood Stem Cell Leukapheresis
Jill Adamski, MD, PhD

Evaluation of Single Needle Platelet Procedure Time using AMICUS 3.X Software
Eric Senaldi, MD

Evaluation of AMICUS 3.X And Trima Accel for Platelet Collection
Julio Merizalde, DPT/ASCP

Evaluation of Platelet Storage Fluid Transfer Accuracy using AMICUS 3.X Software
Eric Senaldi, MD

Education Session V: Basic Donor Apheresis